FOLFIRI as second-line treatment of metastatic biliary tract cancer patients

• Main Authors: Rafael Caparica (Author), Adrien Lengelé (Author), Winnie Bekolo (Author), Alain Hendlisz (Author)
• Formato: Libro
• Publicado: University of São Paulo, 2019-07-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

The combination of cisplatin and gemcitabine is the standard first-line treatment of metastatic biliary tract cancer (BTC) patients. The benefit of second-line chemotherapy in these patients is controversial. This study aims to evaluate the activity of FOLFIRI (fluorouracil and irinotecan) after fai...